Operates in Healthcare Services — Other healthcare services. Per the activity note to the FY2021 annual report, the company operates a hospital. Founded on 6 July 2010; 100% owned by New Visions University; operates hospital facilities.
Subsidiary of Arasametsarmeo (100.0%)
| Ratio | 2018 | 2019 | 2020 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 88.0% | 90.4% | 69.0% |
| EBITDA Margin | 21.9% | 10.1% | -1.2% |
| EBITDAR | 992 | 317 | -4 |
| EBITDAR Margin | 23.0% | 10.4% | -1.1% |
| EBIT Margin | 13.3% | 4.6% | -106.8% |
| Net Profit Margin | 10.0% | 3.5% | -106.8% |
| Operating Expense % of Sales | 66.1% | 80.4% | 70.1% |
| Returns | |||
| Return on Assets (ROA) | 11.9% | 3.4% | -18.0% |
| Return on Equity (ROE) | 16.6% | 6.0% | -29.1% |
| ROIC [EBIT / Invested Capital] | 20.1% | 7.4% | -29.7% |
| Leverage & debt balances | |||
| Debt-to-Assets | 7.1% | 5.2% | 0.0% |
| Debt-to-Equity | 0.10x | 0.09x | 0.00x |
| Debt-to-EBITDA | 0.27x | 0.54x | N/A |
| Equity-to-Assets | 71.9% | 55.9% | 62.0% |
| Net Debt | 254 | 161 | -28 |
| Cash & Equivalents | 2 | 3 | 28 |
| Total Debt | 257 | 164 | N/A |
| Liquidity & working capital | |||
| Current Ratio | 2.02x | 1.53x | 73.19x |
| Quick Ratio | 2.02x | 1.34x | 63.43x |
| Cash Ratio | 0.00x | 0.01x | 12.49x |
| Total Current Assets | 1,145 | 772 | 166 |
| Total Current Liabilities | 568 | 503 | 2 |
| Inventory | N/A | 97 | 22 |
| Trade Receivables | 257 | 158 | 45 |
| Trade Payables | 278 | 237 | 2 |
| Net Working Capital | 577 | 269 | 163 |
| Net Working Capital % of Revenue | 13.4% | 8.8% | 44.0% |
| Trade Working Capital | -21 | 18 | 64 |
| Trade Working Capital % of Revenue | -0.5% | 0.6% | 17.4% |
| Change in Trade Working Capital | N/A | 39 | 47 |
| Turnover & efficiency | |||
| Inventory Turnover | N/A | 3.01x | 5.21x |
| Days Inventory Outstanding (DIO) | N/A | 121.2 | 70.1 |
| Receivables Turnover | 16.82x | 19.26x | 8.31x |
| Days Sales Outstanding (DSO) | 21.7 | 19.0 | 43.9 |
| Payables Turnover | 1.87x | 1.23x | 50.82x |
| Days Payable Outstanding (DPO) | 195.6 | 297.2 | 7.2 |
| Cash Conversion Cycle | -173.9 days | -157.0 days | 106.8 days |
| Asset Turnover | 1.19x | 0.97x | 0.17x |
| Cash flow & dividends | |||
| Operating Cash Flow | 5 | 1 | 25 |
| Free Cash Flow (OCF − Capex proxy) | 5 | 1 | 25 |
| Cash Conversion (OCF / EBITDA) | 0.5% | 0.3% | N/A |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →